{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:55:58Z","timestamp":1785758158151,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.exphem.2024.104670","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:57:49Z","timestamp":1730771869000},"page":"104670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia"],"prefix":"10.1016","volume":"140","author":[{"given":"Jianping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5919-9147","authenticated-orcid":false,"given":"Weiru","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2874-3300","authenticated-orcid":false,"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2024.104670_bib0001","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104670_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104670_bib0003","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104670_bib0004","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.17403","article-title":"Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries","volume":"194","author":"Scheinberg","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12185-013-1382-0","article-title":"The biology of thrombopoietin and thrombopoietin receptor agonists","volume":"98","author":"Kuter","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault De Latour","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2024.104670_bib0007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3324\/haematol.2021.278413","article-title":"Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag","volume":"107","author":"Zaimoku","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104670_bib0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104670_bib0009","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2040620717693573","article-title":"From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag","volume":"8","author":"Gill","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0010","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s40265-018-0949-8","article-title":"Avatrombopag: First Global Approval","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.exphem.2024.104670_bib0011","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exphem.2024.104670_bib0012","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/bjh.15573","article-title":"Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia","volume":"183","author":"Jurczak","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221127532","article-title":"Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation","volume":"13","author":"Zhou","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102158","article-title":"Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China","volume":"7","author":"Mei","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.exphem.2024.104670_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajh.27080","article-title":"Avatrombopag for adults with early versus chronic immune thrombocytopenia","volume":"99","author":"Virk","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0016","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2224044","article-title":"Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory\/relapsed\/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial","volume":"55","author":"Wan","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.exphem.2024.104670_bib0017","first-page":"952","article-title":"[Avatrombopag combined with standard immunosuppressive therapy in the treatment of severe aplastic anemia with hepatic impairment in six patients]","volume":"43","author":"Li","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.exphem.2024.104670_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2024.104670_bib0019","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","article-title":"Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party","volume":"70","author":"Bacigalupo","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exphem.2022.11.002","article-title":"Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study","volume":"117","author":"Chi","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0021","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2478\/jtim-2023-0006","article-title":"Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease","volume":"11","author":"Wang","year":"2023","journal-title":"J Transl Intern Med"},{"key":"10.1016\/j.exphem.2024.104670_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231191310","article-title":"Comparison of eltrombopag and avatrombopag in the treatment of refractory\/relapsed aplastic anemia: a single-center retrospective study in China","volume":"14","author":"Zhang","year":"2023","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0023","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1142\/S0192415X21500415","article-title":"Avatrombopag for the treatment of SAA with abnormal hepatic and renal function: favorable efficacy and well tolerated","author":"Liu","year":"2021","journal-title":"Chin J Pract Intern Med"},{"key":"10.1016\/j.exphem.2024.104670_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076246","article-title":"Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-na\u00efve and relapsed\/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials","volume":"14","author":"McQuilten","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.exphem.2024.104670_bib0025","article-title":"Inefficacy of immunosuppressive therapy for severe aplastic anemia progressing from non-SAA: improved outcome after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2024.104670_bib0026","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ajh.25081","article-title":"First-line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012","volume":"93","author":"Bacigalupo","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.seminhematol.2021.12.002","article-title":"Aplastic anemia: pathophysiology","volume":"59","author":"Giudice","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0028","article-title":"Predicting response of severe aplastic anemia to rabbit-antithymocyte immunoglobulin based immunosuppressive therapy combined with eltrombopag","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2024.104670_bib0029","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","article-title":"Thrombopoietin receptor agonists: ten years later","volume":"104","author":"Ghanima","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2024.104670_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40164-023-00377-3","article-title":"Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study","volume":"12","author":"Yang","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.exphem.2024.104670_bib0031","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","article-title":"Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome","volume":"289","author":"Rosenfeld","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.exphem.2024.104670_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0037-1963(00)90033-7","article-title":"Late clonal diseases of treated aplastic anemia","volume":"37","author":"Soci\u00e9","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2024.104670_bib0033","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.3390\/ijms20123013","article-title":"New small molecule drugs for thrombocytopenia: chemical, pharmacological, and therapeutic use considerations","volume":"20","author":"Clemons Bankston","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2024.104670_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100909","article-title":"The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag","volume":"53","author":"Kuter","year":"2022","journal-title":"Blood Rev"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X24005356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:34:17Z","timestamp":1733225657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X24005356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"alternative-id":["S0301472X24005356"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104670","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2024.104670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104670"}}